| Sponsors' profile |
 |
The British Society for Rheumatology would like to acknowledge and thank our sponsors and exhibitors for their generous support and whose contribution to the Autumn Conference: case-based discussions 2014 is invaluable. |
| Swedish Orphan |  |
| Sobi is an international specialty healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on inflammation and genetic diseases, with three late stage biological development projects within hemophilia and neonatology. |
|
| Janssen |  |
| At Janssen, we are dedicated to addressing and solving some of the most important unmet needs of our time in immunology, oncology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. |
|
| UCB Pharma Ltd |
 |
| UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. |
|
| Pfizer |  |
| WORKING TOGETHER FOR A HEALTHIER WORLD™ At Pfizer, we strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. In the UK, Pfizer has its business headquarters in Surrey and is the major supplier of medicines to the NHS. To learn more about our commitments, please visit us at www.pfizer.co.uk. |
|
| MSD |
 |
| Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products we work with customers to bring innovative healthcare solutions to those who need them the most. We demonstrate our commitment to increasing access to healthcare through far-reaching policies, programmes and partnerships. MSD is a trade name of Merck & Co., Inc., with headquarters in U.S.A. www.msd-uk.com. |
|
| Celgene |  |
| Celgene Corporation is a global biopharmaceutical company that is helping healthcare providers address serious conditions, such as cancer and immune-inflammatory diseases. This dedication to medical progress goes hand-in-hand with our industry-leading patient support and access programs. Together, these aspects form the core of our commitment to patients worldwide. |
|
| Roche Products Ltd and Chugai Pharma UK Ltd |
  |
| As a supplier of innovative product and services for the early detection, prevention, diagnosis and treatment of diseases, Roche contributes on a broad range of fronts to improving people’s health and QOL. Chugai’s mission is to dedicate itself to adding exceptional value through the creation of innovative medical products and services for the benefit of the medical community and human health. |
|
| AbbVie |  |
| At AbbVie, we have the expertise and structure of a proven pharmaceutical leader, and the focus and passion of an entrepreneur and innovator. The result is something rare in health care today - a company that has the ability to discover and reach all corners of the globe with treatment options that can improve people’s lives. |
|
| Consilient Health Ltd |
 |
| Consilient Health is a young, dynamic, rapidly growing pharmaceutical company with Brands Portfolio of Women’s Health and Bone Health pharmaceutical products. Bone Health is an area we are focused on. Developing a range of products to meet the unmet needs of clinicians and patients through both product development and effective product support post-launch. References 1. DM&D August 2014 CH-OCS-4017-08/2014 Date of Preparation August 2014. |
|
